title: L-Tryptophan Production by Auxotrophic and Analogue Resistant Mutants of Aureobacterium flavescens.
abstract: A number of tyrosine plus phenylalanine double auxotrophic mutants were isolated by N-methyl-N-nitro-N-nitrosoguanidine (MNNG) treatment of a locally isolated strain of Aureobacterium flavescens of which 11A(39) and 11A(17) were selected on the basis of their tryptophan production in a mineral salt medium over other isolated mutant strains. The mutational block in the aromatic amino acid biosynthetic pathway of the selected double auxotrophs were determined. By controlling pH of the production medium to near neutrality, the active growth period could be extended up to 72 h and more tryptophan was accumulated compared to pH unregulated culture where the active growth ceased after 48 h. Further improvement of the tryptophan production has been achieved by stepwise isolation of a mutant strain resistant to the tryptophan analogues p-fluorotryptophan (FT) and 5-methyl tryptophan (MT) from the 11A(39). Demand for L-tryptophan as food additive and therapeutic agent is increasing day by day throughout the World, particularly in the underdeveloped and developing countries like India. Still to date India depends on other countries for L-tryptophan. The aim of this work is to develop a potent high yielding, feed back insensitive mutant strain and optimization of its medium pH for maximum production of tryptophan.
authors.affiliation: Department of Microbiology, MUC Women's College, Burdwan, West Bengal, India.
authors.forename: A
authors.initials: A
authors.lastname: Roy
authors.forename: S K
authors.initials: SK
authors.lastname: Mukhopadhyay
references.citation: Appl Environ Microbiol. 2004 Mar;70(3):1852-4
references.pmid: 15006816
references.citation: Expert Rev Mol Med. 2006 Aug 31;8(20):1-27
references.pmid: 16942634
references.citation: World J Microbiol Biotechnol. 1995 Nov;11(6):665-8
references.pmid: 24415018
references.citation: Appl Environ Microbiol. 2005 Apr;71(4):1803-10
references.pmid: 15812004
references.citation: J Psychiatry Neurosci. 2000 Sep;25(4):337-46
references.pmid: 11022398
references.citation: J Neural Transm (Vienna). 2005 Apr;112(4):577-85
references.pmid: 15372327
references.citation: Trends Biotechnol. 1996 Jul;14(7):250-6
references.pmid: 8771798
references.citation: Anal Chem. 1975 Jul;47(8):1429-32
references.pmid: 1147264
references.citation: Genet Mol Res. 2004 Mar 31;3(1):85-91
references.pmid: 15100990
references.citation: J Biotechnol. 2003 Sep 4;104(1-3):155-72
references.pmid: 12948636